
The HIV treatment market is increasingly being shaped by therapies designed to reduce medication burden and improve convenience, with long-acting …
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader

